Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism
- 24 March 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (6) , 1277-1282
- https://doi.org/10.1016/0006-2952(93)90280-a
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Introduction and HistoryPublished by S. Karger AG ,2015
- Clinical Pharmacokinetics of SulfonamidesPublished by S. Karger AG ,2015
- Sulfamethoxazole is metabolized to the hydroxylamine in humansClinical Pharmacology & Therapeutics, 1992
- Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactionsClinical Pharmacology & Therapeutics, 1991
- Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional ExpressionDNA and Cell Biology, 1990
- Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.Journal of Clinical Investigation, 1990
- An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogsVeterinary Research Communications, 1990
- N-acetyltransferasePharmacology & Therapeutics, 1989
- The Immunologic and Metabolic Basis of Drug HypersensitivitiesAnnual Review of Pharmacology and Toxicology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976